Ambu AS ADR AMBBY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $10.23
- Day Range
- $11.00–11.00
- 52-Week Range
- $8.55–16.78
- Bid/Ask
- $10.14 / $11.29
- Shares Outstanding
- 260.65M
- Market Cap
- $2.91B
- Volume/Avg
- 202 / 1,054
Key Statistics
- Price/Earnings (Normalized)
- 33.10
- Price/Sales
- 3.00
- Dividend Yield (Trailing)
- 0.58%
- Dividend Yield (Forward)
- 0.58%
- Dividend Payment Schedule
- Dec
- Total Yield
- 0.58%
Company Profile
Ambu AS provides medical technology solutions. The company’s business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 5,498
- Website
- https://www.ambu.com
Valuation
|
Metric
|
AMBBY
|
|---|---|
Price/Earnings (Normalized) | 33.10 |
Price/Book Value | 3.07 |
Price/Sales | 3.00 |
Price/Cash Flow | 18.18 |
Price/Earnings
AMBBY
Financial Strength
|
Metric
|
AMBBY
|
|---|---|
Quick Ratio | 1.58 |
Current Ratio | 2.77 |
Interest Coverage | 11.95 |
Quick Ratio
AMBBY
Profitability
|
Metric
|
AMBBY
|
|---|---|
Return on Assets (Normalized) | 7.05% |
Return on Equity (Normalized) | 8.86% |
Return on Invested Capital (Normalized) | 8.61% |
Return on Assets
AMBBY
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|<lB&$#! | LOCK|SJ^$ | $172B | |||
| Medtronic PLC
MDT
| LOCK|N!!S@fW | LOCK|hdVv | $113B | |||
| Stryker Corp
SYK
| LOCK|mvvQF$! | LOCK|%D! | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|?r@$!%& | LOCK|C&hX& | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|<J#N>pt | LOCK|<>X^s | $49B | |||
| DexCom Inc
DXCM
| LOCK|?<<^<?p | LOCK|?%yx | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^H$@>b& | LOCK|@Y | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|b?Q | LOCK|$&> | $24B | |||
| Steris PLC
STE
| LOCK|mzGM^G | LOCK|!C>C | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|lNnW!RvL | LOCK|dys | $17B |
United States